Multisite and bidirectional exonic splicing enhancer in CD44 alternative exon v3

RNA

Volumn 13, Issue 12, 2007, Pages 2312-2323

  Vela, Elena ^a,b,c   Hilari, Josep M ^b,c   Roca, Xavier ^a,b,d   Muñoz Mármol, Ana M ^b   Ariza, Aurelio ^b   Isamat, Marcos ^a  

^a Fundacion Echevarne   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c Lab de Analisis Dr Echevarne   (Spain)

^d Simons Center for Quantitative Biology   (United States)

Author keywords

Alternative splicing; CD44 gene; Exonic splicing enhancer; v3 inclusion

Indexed keywords

MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CD44 GENE; CONTROLLED STUDY; DNA FLANKING REGION; EXON; GENE; GENE FUNCTION; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; HUMAN; HUMAN CELL; INTRON; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA ANALYSIS; RNA SPLICING;

ALTERNATIVE SPLICING; ANTIGENS, CD44; CELL LINE, TUMOR; DNA PRIMERS; ENHANCER ELEMENTS (GENETICS); EXONS; GENE EXPRESSION REGULATION; GENOME; HUMANS; MUTAGENESIS, INSERTIONAL; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; RNA, MESSENGER; VARIATION (GENETICS);

EID: 36249027022     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.732807     Document Type: Article

References (36)

1. Bajorath, J. 2000. Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions. Proteins 39: 103-111.
2. Bell, M.V., Cowper, A.E., Lefranc, M.P., Bell, J.I., and Screaton, G.R. 1998. Influence of intron length on alternative splicing of CD44. Mol. Cell. Biol. 18: 5930-5941.
3. Bourgeois, C.F., Popielarz, M., Hildwein, G., and Stevenin, J. 1999. Identification of a bidirectional splicing enhancer: Differential involvement of SR proteins in 5′ or 3′ splice-site activation. Mol. Cell. Biol. 19: 7347-7356.
4. Breitbart, R.E., Andreadis, A., and Nadal-Ginard, B. 1987. Alternative splicing: A ubiquitous mechanism for the generation of multiple protein isoforms from single genes. Annu. Rev. Biochem. 56: 467-495.
5. Cartegni, L., Chew, S.L., and Krainer, A.R. 2002. Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat. Rev. Genet. 3: 285-298.
6. Cartegni, L., Wang, J., Zhu, Z., Zhang, M.Q., and Krainer, A.R. 2003. ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31: 3568-3571. doi: 10.1093/nar/gkg616.
7. Cooper, T.A. 2005. Use of minigene systems to dissect alternative splicing elements. Methods 37: 331-340.
8. Fairbrother, W.G., Yeh, R.F., Sharp, P.A., and Burge, C.B. 2002. Predictive identification of exonic splicing enhancers in human genes. Science 297: 1007-1013.
9. Fairbrother, W.G., Yeo, G.W., Yeh, R., Goldstein, P., Mawson, M., Sharp, P.A., and Burge, C.B. 2004. RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons. Nucleic Acids Res. 32: W187-W190. doi: 10.1093/nar/gkh393.
10. Goren, A., Ram, O., Amit, M., Keren, H., Lev-Maor, G., Vig, I., Pupko, T., and Ast, G. 2006. Comparative analysis identifies exonic splicing regulatory sequences - The complex definition of enhancers and silencers. Mol. Cell 22: 769-781.
11. Graveley, B.R. 2000. Sorting out the complexity of SR protein functions. RNA 6: 1197-1211.
12. Graveley, B.R. 2001. Alternative splicing: Increasing diversity in the proteomic world. Trends Genet. 17: 100-107.
13. Gunthert, U., Stauder, R., Mayer, B., Terpe, H.J., Finke, L., and Friedrichs, K. 1995. Are CD44 variant isoforms involved in human tumour progression? Cancer Surv. 24: 19-42.
14. Herrlich, P., Zoller, M., Pals, S.T., and Ponta, H. 1993. CD44 splice variants: Metastases meet lymphocytes. Immunol. Today 14: 395-399.
15. Hertel, K.J. and Maniatis, T. 1998. The function of multisite splicing enhancers. Mol. Cell 1: 449-455.
16. Lam, B.J., Bakshi, A., Ekinci, F.Y., Webb, J., Graveley, B.R., and Hertel, K.J. 2003. Enhancer-dependent 5′-splice-site control of fruitless pre-mRNA splicing. J. Biol. Chem. 278: 22740-22747.
17. Lavigueur, A., La Branche, H., Kornblihtt, A.R., and Chabot, B. 1993. A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes & Dev. 7: 2405-2417.
18. Lesley, J., Hyman, R., English, N., Catterall, J.B., and Turner, G.A. 1997. CD44 in inflammation and metastasis. Glycoconj. J. 14: 611-622.
19. Liu, H.X., Cartegni, L., Zhang, M.Q., and Krainer, A.R. 2001. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat. Genet. 27: 55-58.
20. Ponta, H., Sherman, L., and Herrlich, P.A. 2003. CD44: From adhesion molecules to signaling reglators. Nat. Rev. Mol. Cell Biol. 4: 33-45.
21. Ramchatesingh, J., Zahler, A.M., Neugebauer, K.M., Roth, M.B., and Cooper, T.A. 1995. A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol. Cell. Biol. 15: 4898-4907.
22. Reed, R. 1996. Initial splice-site recognition and pairing during pre-mRNA splicing. Curr. Opin. Genet. Dev. 6: 215-220.
23. Reed, R. and Palandjian, L. 1997. Spliceosome assembly. In Eukaryotic mRNA processing (ed. A.R. Krainer), pp. 103-129. Oxford University Press, Oxford, UK.
24. Roca, X., Mate, J.L., Ariza, A., Munoz-Marmol, A.M., Von Uexkull-Guldeband, C., Pellicer, I., Navas-Palacios, J.J., and Isamat, M. 1998. CD44 isoform expression follows two alternative splicing pathways in breast tissue. Am. J. Pathol. 153: 183-190.
25. Ruiz, P., Schwarzler, C., and Gunthert, U. 1995. CD44 isoforms during differentiation and development. Bioessays 17: 17-24.
26. Screaton, G.R., Bell, M.V., Jackson, D.G., Cornelis, F.B., Gerth, U., and Bell, J.I. 1992. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. 89: 12160-12164.
27. Sheth, N., Roca, X., Hastings, M.L., Roeder, T., Krainer, A.R., and Sachidanandam, R. 2006. Comprehensive splice-site analysis using comparative genomics. Nucleic Acids Res. 34: 3955-3967. doi: 10.1093/nar/gkl556.
28. Stamenkovic, I., Amiot, M., Pesando, J.M., and Seed, B. 1989. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56: 1057-1062.
29. Stamm, S., Ben-Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, D., Thanaraj, T.A., and Soreq, H. 2005. Function of alternative splicing. Gene 344: 1-20.
30. Tanaka, K., Watakabe, A., and Shimura, Y. 1994. Polypurine sequences within a downstream exon function as a splicing enhancer. Mol. Cell. Biol. 14: 1347-1354.
31. Vela, E., Roca, X., and Isamat, M. 2006. Identification of novel splice variants of the human CD44 gene. Biochem. Biophys. Res. Commun. 343: 167-170.
32. Watakabe, A., Tanaka, K., and Shimura, Y. 1993. The role of exon sequences in splice site selection. Genes & Dev. 7: 407-418.
33. Xu, R., Teng, J., and Cooper, T.A. 1993. The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol. Cell. Biol. 13: 3660-3674.
34. Zhang, X.H. and Chasin, L.A. 2004. Computational definition of sequence motifs governing constitutive exon splicing. Genes & Dev. 18: 1241-1250.
35. Zhang, X.H., Kangsamaksin, T., Chao, M.S., Banerjee, J.K., and Chasin, L.A. 2005. Exon inclusion is dependent on predictable exonic splicing enhancers. Mol. Cell. Biol. 25: 7323-7332.
36. Zhu, J., Shendure, J., Mitra, R.D., and Church, G.M. 2003. Single molecule profiling of alternative pre-mRNA splicing. Science 301: 836-838.